Neuroprotective effect of quercetin on the duodenum enteric nervous system of streptozotocin-induced diabetic rats

Digestive Diseases and Sciences

Volumn 57, Issue 12, 2012, Pages 3106-3115

  Lopes, Cláudia Regina Pinheiro ^a   Ferreira, Paulo Emílio Botura ^a   Zanoni, Jacqueline Nelisis ^a   Alves, Angela Maria Pereira ^a   Alves, Éder Paulo Belato ^a   Buttow, Nilza Cristina ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Diabetes; Myenteric plexus; Neuroprotection; Quercetin; Submucosal plexus

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; QUERCETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DUODENUM; GLIA CELL; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; MALE; MYENTERIC PLEXUS; NERVE CELL; NEURONAL HYPERTROPHY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DUODENUM; ENTERIC NERVOUS SYSTEM; FEMALE; MALE; MYENTERIC PLEXUS; NEURONS; NEUROPROTECTIVE AGENTS; QUERCETIN; RATS; RATS, WISTAR; STREPTOZOCIN; SUBMUCOUS PLEXUS;

EID: 84871638998     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2300-7     Document Type: Article

References (48)

1. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167-178.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
3. Hoeldtke RD, Bryner KD, VanDyke K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 2011;21:19-28.
4. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612-628.
5. Izbeki F, Wittman T, Rosztoczy A, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192-198.
6. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Int Med. 2001;161:1989-1996.
7. Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 2002;16:123-125.
8. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995;33:1061-1080.
9. Shirai M, Yamanishi R, Moon JH, Murota K, Terao J. Effect of quercetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Biosci Biotechnol Biochem. 2002;66:1015-1021.
10. Arredondo F, Echeverry C, Abin-Carriquiry JA, Blasina F, Antunez K, Jones DP, Go YM, Liang YL, Dajas F. After cellular internalization, quercetin causes nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med. 2010;49:738-747.
11. De Freitas P, Natali MR, Pereira RV, Miranda Neto MH, Zanoni JN. Myenteric neurons and intestinal mucosa of diabetic rats after ascorbic acid supplementation. World J Gastroenterol. 2008;14:6518-6524.
12. Pereira RV, de Miranda-Neto MH, da Silva Souza ID, Zanoni JN. Vitamin e supplementation in rats with experimental diabetes mellitus: analysis of myosin-v and nnos immunoreactive myenteric neurons from terminal ileum. J Mol Histol. 2008;39:595-603.
13. Fregonesi CE, Molinari SL, Alves AM, et al. Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-l-carnitine. Anat Histol Embryol. 2005;34:93-97.
14. da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol. 2011;17:898-905.
15. Tashima CM, Tronchini EA, Pereira RV, Bazotte RB, Zanoni JN. Diabetic rats supplemented with l-glutamine: a study of immunoreactive myosin-v myenteric neurons and the proximal colonic mucosa. Dig Dis Sci. 2007;52:1233-1241.
16. Roldi LP, Pereira RV, Tronchini EA, et al. Vitamin e (alpha-tocopherol) supplementation in diabetic rats: effects on the proximal colon. BMC Gastroenterol. 2009;9:88.
17. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951-960.
18. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci. 2008;9:36-45.
19. Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus: pathogenesis of long-term complications. Eur J Internal Med. 1999;10:9-19.
20. Shirpoor A, Ansari MH, Salami S, Pakdel FG, Rasmi Y. Effect of vitamin e on oxidative stress status in small intestine of diabetic rat. World J Gastroenterol. 2007;13:4340-4344.
21. Myhrstad MC, Carlsen H, Nordstrom O, Blomhoff R, Moskaug JO. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med. 2002;32:386-393.
22. Hollman PC, Gaag VDM, Mengelers MJ, van Trijp JM, de Vries JH, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med. 1996;21:703-707.
23. Hollman PC, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother. 1997;51:305-310.
24. Takahashi T, Nakamura K, Itoh H, Sima AA, Owyang C. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology. 1997;113:1535-1544.
25. Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A. Nitric oxide synthase (nos) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci. 1997;42:2106-2110.
26. Yoneda S, Kadowaki M, Kuramoto H, Fukui H, Takaki M. Enhanced colonic peristalsis by impairment of nitrergic enteric neurons in spontaneously diabetic rats. Auton Neurosci. 2001;92:65-71.
27. Belai A, Cooper S, Burnstock G. Effect of age on nadph-diaphorase- containing myenteric neurones of rat ileum and proximal colon. Cell Tissue Res. 1995;279:379-383.
28. Santer RM. Survival of the population of nadph-diaphorase stained myenteric neurons in the small intestine of aged rats. J Auton Nerv Syst. 1994;49:115-121.
29. Zanoni JN, Hernandes L, Bazotte RB, Miranda Neto MH. Terminal ileum submucous plexus: study of the vip-ergic neurons of diabetic rats treated with ascorbic acid. Arq Neuropsiquiatr. 2002;60:32-37.
30. Nagahama M, Semba R, Tsuzuki M, Aoki E. l-arginine immunoreactive enteric glial cells in the enteric nervous system of rat ileum. Biol Signals Recept. 2001;10:336-340.
31. Porter AJ, Wattchow DA, Brookes SJ, Costa M. Projections of nitric oxide synthase and vasoactive intestinal polypeptide-reactive submucosal neurons in the human colon. J Gastroenterol Hepatol. 1999;14:1180-1187.
32. Lin Z, Sandgren K, Ekblad E. Increased expression of nitric oxide synthase in cultured neurons from adult rat colonic submucous ganglia. Auton Neurosci. 2004;114:29-38.
33. Zucoloto S, Diaz JA, Oliveira JS, Muccilo G, Sales Neto VN, Kajiwara JK. Effect of chemical ablation of myenteric neurones on intestinal cell proliferation. Cell Tissue Kinet. 1988;21:213-219.
34. Montaner B, Asbert M, Perez-Tomas R. Immunolocalization of transforming growth factor-alpha and epidermal growth factor receptor in the rat gastroduodenal area. Dig Dis Sci. 1999;44:1408-1416.
35. Yoshikawa I. Effects of epidermal growth factor on alkaline secretion and mucus formation in rat duodenum exposed to luminal acid. Gastroenterol Jpn. 1993;28:496-504.
36. Moriez R, Abdo H, Chaumette T, Faure M, Lardeux B, Neunlist M. Neuroplasticity and neuroprotection in enteric neurons: role of epithelial cells. Biochem Biophys Res Commun. 2009;382:577-582.
37. Cabarrocas J, Savidge TC, Liblau RS. Role of enteric glial cells in inflammatory bowel disease. Glia. 2003;41:81-93.
38. Bassotti G, Villanacci V. Can "Functional" constipation be considered as a form of enteric neuro-gliopathy? Glia. 2011;59:345-350.
39. Wang L, Colodner KJ, Feany MB. Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an alexander disease model. J Neurosci. 2011;31:2868-2877.
40. Shih AY, Johnson DA, Wong G, et al. Coordinate regulation of glutathione biosynthesis and release by nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci. 2003;23:3394-3406.
41. Belai A, Calcutt NA, Carrington AL, Diemel LT, Tomlinson DR, Burnstock G. Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. J Auton Nerv Syst. 1996;58:163-169.
42. Spangeus A, Suhr O, El-Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol. 2000;15:739-744.
43. Eaker EY, Sallustio JE, Marchand SD, Sahu A, Kalra SP, Sninsky CA. Differential increase in neuropeptide y-like levels and myenteric neuronal staining in diabetic rat intestine. Regul Pept. 1996;61:77-84.
44. Shotton HR, Lincoln J. Diabetes only affects nitric oxide synthase-containing myenteric neurons that do not contain heme oxygenase 2. Brain Res. 2006;1068:248-256.
45. Shotton HR, Adams A, Lincoln J. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum. Auton Neurosci. 2007;132:16-26.
46. Cellek S. Point of no return for nitrergic nerves in diabetes: a new insight into diabetic complications. Curr Pharm Des. 2004;10:3683-3695.
47. Courderot-Masuyer C, Lahet JJ, Verges B, Brun JM, Rochette L. Ascorbyl free radical release in diabetic patients. Cell Mol Biol. 2000;46:1397-1401.
48. Kumari K, Umar S, Bansal V, Sahib MK. Monoaminoguanidine inhibits aldose reductase. Biochem Pharmacol. 1991;41:1527-1528.